Here is What Hedge Funds Think About Ariad Pharmaceuticals, Inc. (ARIA)

Page 1 of 2

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shareholders have witnessed an increase in activity from the world’s largest hedge funds of late.

To the average investor, there are a multitude of indicators market participants can use to watch publicly traded companies. A pair of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best investment managers can trounce the broader indices by a solid margin (see just how much).

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)Equally as integral, positive insider trading sentiment is a second way to parse down the investments you’re interested in. As the old adage goes: there are lots of motivations for a corporate insider to drop shares of his or her company, but only one, very clear reason why they would behave bullishly. Several academic studies have demonstrated the valuable potential of this strategy if investors know where to look (learn more here).

With these “truths” under our belt, let’s take a gander at the recent action regarding Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).

What have hedge funds been doing with Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)?

At the end of the first quarter, a total of 30 of the hedge funds we track held long positions in this stock, a change of 36% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists a few noteworthy hedge fund managers who were upping their stakes significantly.

Of the funds we track, Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management had the biggest position in Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), worth close to $73.8 million, accounting for 2.3% of its total 13F portfolio. The second largest stake is held by Dan Loeb of Third Point, with a $49.7 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Phill Gross and Robert Atchinson’s Adage Capital Management, Julian Baker and Felix Baker’s Baker Bros. Advisors and Donald Chiboucis’s Columbus Circle Investors.

As one would reasonably expect, some big names were breaking ground themselves. Millennium Management, managed by Israel Englander, initiated the biggest position in Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). Millennium Management had 10.7 million invested in the company at the end of the quarter. James E. Flynn’s Deerfield Management also initiated a $5.5 million position during the quarter. The other funds with brand new ARIA positions are Glenn Russell Dubin’s Highbridge Capital Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Louis Bacon’s Moore Global Investments.

How have insiders been trading Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)?

Insider trading activity, especially when it’s bullish, is best served when the company in focus has experienced transactions within the past half-year. Over the last half-year time period, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has experienced zero unique insiders buying, and 11 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). These stocks are Theravance Inc (NASDAQ:THRX), Seattle Genetics, Inc. (NASDAQ:SGEN), Incyte Corporation (NASDAQ:INCY), Medivation Inc (NASDAQ:MDVN), and Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). This group of stocks are the members of the biotechnology industry and their market caps are similar to ARIA’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!